Research
Research

Bacterial Toxin Linked to Surge in Bowel Cancer Among Under-50s

By Renee Doyle ·

Why Colibactin Is the Prime Suspect

Scientists have identified a bacterial toxin as a leading suspect in the sharp rise of bowel cancer among people under 50. The finding was presented to UK MPs, who were told that early-life exposure to colibactin may be a key driver of this troubling trend.

Bowel cancer cases in young adults have doubled in many countries over the past twenty years. While rising obesity and declining physical activity contribute to this increase, researchers argue that these factors alone cannot fully explain the surge.

What Does This Mean for Prevention?

Colibactin is a toxin produced by certain strains of E. coli. The bacteria colonize the gut, and the toxin can damage DNA in the lining of the colon. This damage can trigger the genetic changes that lead to cancer. Exposure in early life, when the gut is developing, appears particularly harmful.

If early-life exposure is the main driver, then reducing E. coli colonization in infants and young children could lower future cancer risk. Researchers are now investigating how common this exposure is and whether existing hygiene practices or diet changes can reduce it.

What is colibactin? Colibactin is a toxin made by specific E. coli strains. It can damage DNA in the gut lining, potentially starting the process that leads to bowel cancer.

Frequently Asked Questions

How has bowel cancer in under-50s changed recently? Cases have doubled in many countries over the last two decades, a trend that cannot be explained by lifestyle factors alone.

Can early-life exposure be reduced? Researchers are studying whether better hygiene, diet, or medical interventions in childhood can lower the risk of developing bowel cancer later in life.